Journal of Virology · 1994 · 281 citations · 29 references
Life SciencesImmunologyInfectious DiseasesMolecular VirologyMonoclonal AntibodiesVirologyAntibody CharacterizationAntibody-antigen RecognitionAntigen RecognitionB-cell ResponsesVaccine Antigen DiscoveryViral VaccinesAmino AcidsAntibody-mediated Viral NeutralizationAntibody-mediated Virus NeutralizationB-cell Epitope DiscoveryB-cell Epitope VaccinesB-cell EpitopesNeutralizing Antibody ResponsesStructural Basis Of Antigenicity
Previously we identified the highly conserved amino acids Glu-Leu-Asp-Lys-Trp-Ala (ELDKWA) on the ecto-domain of gp41 as the epitope of a neutralizing monoclonal antibody (2F5) directed against human immunodeficiency virus type 1. In the present study, the sequence defining the epitope was introduced into the loop of antigenic site B of the influenza virus hemagglutinin. The resulting chimeric virus was able to elicit ELDKWA-specific immunoglobulins G and A in antisera of mice. Moreover, the distantly related human immunodeficiency virus type 1 isolates MN, RF, and IIIB were neutralized by these antisera. These data suggest that this conserved B-cell epitope is a promising candidate for inclusion in a vaccine against AIDS. The results also show that influenza virus can be used to effectively present the antigenic structure of this B-cell epitope.
29
A simple method of estimating 50 per cent end points
Hr Muench · Medical Entomology and Zoology · 1938 · 8.4K citations
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Thomas Muster, Franz Steindl, Martin Purtscher et al. · Journal of Virology · 1993 · 988 citations · Full text
Andrea Buchacher, RENATE PREDL, K. Strutzenberger et al. · AIDS Research and Human Retroviruses · 1994 · 526 citations